Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-28

Clinical Trial Update: Treatment Frequency Reduction in Pompe Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on reducing treatment frequency for Pompe disease (late-onset); recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Erasmus Medical Center | Conditions: Pompe Disease (Late-onset), GAA Deficiency | Phase 4 | Status: NOT_YET_RECRUITING